Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Action Plan to Combat Antimicrobial Resistance

Overview of the Action Plan

2012 Action Plan [PDF - 40 pages]

Rationale for Action Plan

The Action Plan is a blueprint for specific, coordinated, federal actions to address the growing threat of antimicrobial resistance in the United States. In the Action Plan, the Interagency Task Force on Antimicrobial Resistance (ITFAR) addresses the three areas of federal action: surveillance, prevention and control; research; and regulatory pathways for new products. The Action Plan outlines goals and actions that the participating federal agencies and departments are pursuing or planning to pursue in an effort to respond to the complex public health risk posed by antimicrobial resistance.

Following each of the goals listed for each focus area are several action items that define topic areas for specific projects or implementation steps. Wherever possible, action items are populated with specific projects or implementation steps to provide greater specificity for planned federal activities. The action items, projects and implementation steps do not represent an exhaustive list of activities. Project lists will be updated annually, and actions will be updated every two years.

Focus Area I: Surveillance, Prevention and Control of Antimicrobial Resistant Infections

Overarching Goal: In order to develop and implement effective control strategies there must be 1) continuous or periodic monitoring of infections caused by antimicrobial resistant (AR) microorganisms, 2) comprehensive knowledge of the use of antimicrobial agents across all sectors and 3) the capacity to develop, evaluate and implement effective prevention and containment strategies nationally and globally.

Focus Area II: Research

Overarching Goal: Encourage, conduct and support basic and translational research to enhance our understanding of factors leading to the development of AR microorganisms, their transmission in various settings and optimal modes of prevention, diagnosis and therapy.

Focus Area III: Regulatory Pathways for New Products

Overarching Goal: Encourage the development of products for bacterial disease to improve our capacity to diagnose, prevent and treat infections, including infections caused by resistant microorganisms.

 Top of Page

Acronyms and Abbreviations
AHRQAgency for Healthcare Research and Quality
APHLAssociation of Public Health Laboratories
ARAntimicrobial resistance
ASHOffice of the Assistant Secretary for Health (HHS)
ASPEOffice of the Assistant Secretary for Planning and Evaluation
ASPROffice of the Assistant Secretary for Preparedness and Response
BARDABiomedical Advanced Research Development Authority (HHS)
CDCCenters for Disease Control and Prevention
CLSIClinical and Laboratory Standards Institute
CMSCenters for Medicare and Medicaid Services
CSTECouncil of State and Territorial Epidemiologists
DoDDepartment of Defense
EPAEnvironmental Protection Agency
FDAFood and Drug Administration
HAIHealthcare-associated infection
HAPHospital-acquired pneumonia
HHSDepartment of Health and Human Services
HRSAHealth Resources and Services Administration
IPECInpatient Evaluation Center
MDROMultidrug-resistant organism
MRSAMethicillin-resistant Staphylococcus aureus
NHSNNational Healthcare Safety Network
NIHNational Institutes of Health
USDAUnited States Department of Agriculture
VADepartment of Veterans Affairs
VAPVentilator-associated pneumonia
VHAVeterans Health Administration
XDR TBExtensively drug-resistant tuberculosis